CDH1 Germline Variants in a Tunisian Cohort with Hereditary Diffuse Gastric Carcinoma
Authors:
- Jihenne Ben Aissa-HajJAJihenne Ben Aissa-Haj
- Maria KabbageMKMaria Kabbage
- Houcemeddine OthmenHOHoucemeddine Othmen
- Patrick SaulnierPSPatrick Saulnier
- Haifa Tounsi KettitiHKHaifa Tounsi Kettiti
- Amira Jaballah-GabteniAJAmira Jaballah-Gabteni
- Azer FerahAFAzer Ferah
- Mouna MedhioubMMMouna Medhioub
- Amal KhsibaAKAmal Khsiba
- Moufida MahmoudiMMMoufida Mahmoudi
- Afifa MaaloulAMAfifa Maaloul
- Sonia Ben NasrSNSonia Ben Nasr
Open Access
Abstract
Mutational screening of the CDH1 gene is a standard treatment for patients who fulfill Hereditary Diffuse Gastric Cancer (HDGC) testing criteria. In this framework, the classification of variants found in this gene is a crucial step for the clinical management of patients at high risk for HDGC. The aim of our study was to identify CDH1 as well as CTNNA1 mutational profiles predisposing to HDGC in Tunisia. Thirty-four cases were included for this purpose. We performed Sanger sequencing for the entire coding region of both genes and MLPA (Multiplex Ligation Probe Amplification) assays to investigate large rearrangements of the CDH1 gene. As a result, three cases, all with the HDGC inclusion criteria (8.82% of the entire cohort), carried pathogenic and likely pathogenic variants of the CDH1 gene. These variants involve a novel splicing alteration, a missense c.2281G > A detected by Sanger sequencing, and a large rearrangement detected by MLPA. No pathogenic CTNNA1 variants were found. The large rearrangement is clearly pathogenic, implicating a large deletion of two exons. The novel splicing variant creates a cryptic site. The missense variant is a VUS (Variant with Uncertain Significance). With ACMG (American College of Medical Genetics and Genomics) classification and the evidence available, we thus suggest a revision of its status to likely pathogenic. Further functional studies or cosegregation analysis should be performed to confirm its pathogenicity. In addition, molecular exploration will be needed to understand the etiology of the other CDH1- and CTNNA1-negative cases fulfilling the HDGC inclusion criteria.Keywords
All Related Versions
This publication has 77 references indexed in Scilit:
- Secondary Variants in Individuals Undergoing Exome Sequencing: Screening of 572 Individuals Identifies High-Penetrance Mutations in Cancer-Susceptibility GenesThe American Journal of Human Genetics, 2012
- Germline mutations of the E‐cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancerCancer, 2011
- E‐Cadherin/β‐Catenin Complex and the Epithelial BarrierBioMed Research International, 2011
- Recognition of a signal peptide by the signal recognition particleNature, 2010
- Sub-angstrom modeling of complexes between flexible peptides and globular proteinsProteins: Structure, Function, and Bioinformatics, 2010
- Germline CDH1 deletions in hereditary diffuse gastric cancer familiesHuman Molecular Genetics, 2009
- Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancerHuman Molecular Genetics, 2008
- CDH1/E-cadherin germline mutations in early-onset gastric cancerJournal of Medical Genetics, 2006
- Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindredHuman Mutation, 2002
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993